GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
104 hedge funds and large institutions have $80.8M invested in Sanofi Contingent Value Rights in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Holders
104
Holding in Top 10
2
Calls
$15.2M
Puts
–
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.12M | |
| 3 | +$844K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$580K |
| 5 |
BMO
Beck Mack & Oliver
New York
|
+$147K |
Top Sellers
| 1 | -$2.89M | |
| 2 | -$499K | |
| 3 | -$56.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$43.6K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$25.2K |